Related Experiment Video
Updated: Aug 4, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Severe malaria: lessons learned from the management of critical illness in children
1The Centre for Geographic Medicine Research, Coast, KEMRI, Kenya, PO Box 230, Kilifi, Kenya. kmaitland@kilifi.kemri-wellcome.org
Insights
Two hypotheses explain metabolic acidosis in severe malaria: hypovolaemia and a metabolic cause. Further research is needed to determine the best treatment for this condition.
Area of Science:
- Pediatrics
- Infectious Diseases
- Biochemistry
Background:
- Severe malaria can cause metabolic acidosis (increased blood acidity).
- Two hypotheses explain this acidosis: hypovolaemia (decreased blood volume) and a metabolic cause.
- Current treatment recommendations for acidosis in severe malaria are debated.
Discussion:
- The hypovolaemia hypothesis suggests treatment based on pediatric cardiovascular compromise management.
- The metabolic cause hypothesis proposes dichloroacetate treatment.
- Both hypotheses are plausible and not mutually exclusive, but their risks and benefits are uncertain.
Key Insights:
- Metabolic acidosis in severe malaria has two proposed explanations: hypovolaemia and a metabolic origin.
- Treatment strategies for severe malaria-induced acidosis are not definitively established.
- Uncertainty remains regarding the optimal management of metabolic acidosis in severe malaria.
Outlook:
- Large multicenter, randomized controlled trials are essential to provide evidence for effective treatment.
- Further research should focus on clarifying the complex physiological rationales behind each hypothesis.
- Establishing evidence-based treatment guidelines is crucial for improving outcomes in childhood severe malaria.
Abstract:
Two hypotheses have recently been raised to explain the metabolic acidosis (increased blood acidity) of severe malaria, and both are relevant to treatment. The first suggests that a decreased blood volume (hypovolaemia) has an important role in severe malaria; following this, treatment should be based on the current standard paediatric management of acidosis in children with features of cardiovascular compromise. The second hypothesis contends that acidosis in malaria has a metabolic cause and proposes treatment with dichloroacetate. Both hypotheses are plausible and are not mutually exclusive. In truth, the risks and benefits of either treatment are uncertain, and will remain so until large multicentre, randomised controlled trials provide appropriate supportive evidence. As both views involve complex physiological rationales, beyond the usual scope of this journal, I attempt here to present the largely academic aspects of these hypotheses within the practical and contextual aspects of childhood severe malaria.
More Related Videos
09:04In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Malaria
Bacterial Meningitis I: Introduction